Search Within

Susan Hilton

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Surgery (5)
  5. Urology (5)
  6. Nursing (1)
People
  1. Dean Bajorin (7)
  2. John McCaffrey (7)
  3. Madhu Mazumdar (7)
  4. Harry Herr (5)
  5. William Kelly (5)
  6. Geralyn Higgins (4)

More People

Years
  1. 2000 (3)
  2. 1999 (1)
  3. 1998 (1)
  4. 1997 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (1)
  3. Cancer Investigation (1)
  4. Seminars in Oncology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (1)
  3. Informa Healthcare (1)
  4. Wiley Blackwell (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ifosfamide, paclitaxel, and cisplatin (ITP) in urothelial cancer: The Memorial Sloan-Kettering Cancer Center experience with ITP as a single regimen and preceded by doxorubicin and gemcitabine (AG) in a dose-dense sequenced approach
    Meeting Abstract

    Bajorin, D. F.; McCaffrey, J. A.; Dodd, P.; Hilton, S.; Mazumdar, M.; Donat, S.; Herr, H.; Higgins, G.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Phase I evaluation of sequential doxorubicin + gemcitabine then ifosfamide + paclitaxel + cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Hilton, S.; Mazumdar, M.; Herr, H.; Kelly, W. K.; Icasiano, E.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: Final report of a phase II trial evaluating two dosing schedules
    Journal Article

    Bajorin, D. F.; Mccaffrey, J. A.; Dodd, P. M.; Hilton, S.; Mazumdar, M.; Kelly, W. K.; Herr, H.; Scher, H. I.; Icasiano, E.; Higgins, G.
    Cancer (2000)

    Fulltext@MSK | Save
  • Transitional cell carcinoma (TCC): Status of investigations with ifosfamide, paclitaxel, and cisplatin (ITP)
    Meeting Abstract

    Bajorin, D. F.; Dodd, P. M.; McCaffrey, J. A.; Hilton, S.; Mazumdar, M.; Donat, S.; Herr, H.; Icasiano, E.; Higgins, G.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial
    Journal Article

    Bajorin, D. F.; McCaffrey, J. A.; Hilton, S.; Mazumdar, M.; Kelly, W. K.; Scher, H. I.; Spicer, J.; Herr, H.; Higgins, G.
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma
    Journal Article

    McCaffrey, J. A.; Hilton, S.; Mazumdar, M.; Sadan, S.; Kelly, W. K.; Scher, H. I.; Bajorin, D. F.
    Journal of Clinical Oncology (1997)

    Fulltext@MSK | Save
  • Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma
    Journal Article

    McCaffrey, J. A.; Hilton, S.; Mazumdar, M.; Sadan, S.; Heineman, M.; Hirsch, J.; Kelly, W. K.; Scher, H. I.; Bajorin, D. F.
    Journal of Clinical Oncology (1997)

    Fulltext@MSK | Save